Should a biotech company fund its project with the ROE greater than its cost of...
In our earlier post on valuation, we had discussed whether one should use the licensor’s or licensee’s cost of capital during out licensing. In this issue, we elaborate on the implications of using wrong discount rates. Let’s assume a hypothetical company A…